<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03102944</url>
  </required_header>
  <id_info>
    <org_study_id>HHDx-07998</org_study_id>
    <nct_id>NCT03102944</nct_id>
  </id_info>
  <brief_title>Determining Normal Values of BNP Levels for the Minicare BNP IVD Assay.</brief_title>
  <official_title>Minicare BNP Normal Value Study - MI-BNP-CE02-NV2016</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Handheld Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Handheld Diagnostics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main objective is to determine normal values for Brain Natriuretic Peptide (BNP) levels for
      the Minicare BNP using K2-EDTA (ethylenediaminetetraacetic acid ) venous whole blood and
      K2-EDTA plasma samples from healthy subjects.

      K2-EDTA whole blood and K2-EDTA plasma samples from approximately 150 normal healthy
      volunteer, preferably 50% men and 50% women, will be analysed using the Minicare BNP system.
      This will be a single-center study. The study will consist of a 1-day visit for each study
      subject on which screening based on a questionnaire, blood draw and discharge will occur. For
      each eligible subject, K2-EDTA whole blood will be collected and both K2-EDTA whole blood and
      K2-EDTA plasma will be analyzed using the Minicare BNP. Blood donors, presenting voluntarily
      at one of the Sanquin posts in, the Netherlands (e.g Eindhoven) will be checked on health
      status and selected based on 2 questionnaires. The collected K2-EDTA whole blood tubes from
      eligible subjects will be transferred from the Sanquin posts to Philips Eindhoven for
      Minicare BNP testing. From one subject, both K2-EDTA whole blood and K2-EDTA plasma will be
      measured in singleton. K2-EDTA whole blood and plasma will be measured within 6 hours after
      blood collection. The data obtained will be used for determination of normal values of BNP in
      a healthy population. Leftover plasma samples (without cells/ RNA/DNA) will be aliquoted and
      stored at Philips for potential future analysis/ projects). Testing will be done according to
      a DRAFT Instructions for use (IFU) of the Minicare BNP.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 21, 2017</start_date>
  <completion_date type="Actual">March 24, 2017</completion_date>
  <primary_completion_date type="Actual">March 24, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Normal values for BNP for the Minicare BNP</measure>
    <time_frame>4 weeks</time_frame>
    <description>To determine normal values for BNP levels for the Minicare BNP using K2- EDTA venous whole blood and K2-EDTA plasma samples from healthy subjects.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">160</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <description>no intervention, extra blood tube taken with blood donation at bloodbank and blood is tested on IVD away from patient.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Minicare BNP</intervention_name>
    <description>no real intervention since only leftover materials are used from volunteers and samples are not tested on Minicare BNP IVD device near any volunteer.</description>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Leftover plasma samples (without cells/ RNA/DNA) will be aliquoted and stored at Sponsor for
      potential future analysis/ projects.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â‰¥18 years old

          -  Willing and able to sign the informed consent form (ICF)

        Exclusion Criteria:

          -  Subjects suffering from cardiac and/or vascular disease, renal dysfunction,
             hypertension, cancer, Chronic Obstructive Pulmonary Disease (COPD), instable diabetes,
             pregnancy and extreme overweight are not allowed to donate blood.

          -  Subjects with a history of cardiac and/or vascular disease, renal dysfunction, cancer,
             COPD or instable diabetes are not allowed to donate blood.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diederick Keizer</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Affairs Manager</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Philips EB Handheld Diagnostics</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2017</study_first_posted>
  <last_update_submitted>October 17, 2017</last_update_submitted>
  <last_update_submitted_qc>October 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

